TITLE-XV: TRANSITIONAL AND FINAL PROVISIONS
ARTICLE 138: Review
Please note that this version of the REACH directive is out of date.
Go to new version now
ARTICLE 138: | Review |
1. By 1 June 2019, the Commission shall carry out a review to assess whether or not to extend the application of the obligation
to perform a chemical safety assessment and to document it in a chemical safety report to substances not covered by this obligation because they are not subject to registration or subject to registration but manufactured or imported in quantities of less than 10 tonnes per year. However, for substances meeting the criteria for classification as carcinogenic, mutagenic or toxic for reproduction, category 1 or 2, in accordance with Directive 67/548/EEC, the review shall be carried out by 1 June 2014. When carrying
out the review the Commission shall take into account all relevant factors, including:
(a) the costs for manufacturers and importers of drawing up the chemical safety reports;
(b) the distribution of costs between actors in the supply chain and the downstream user;
(c) the benefits for human health and the environment.
On the basis of these reviews, the Commission may, if appropriate, present legislative proposals to extend this obligation.
2. The Commission may present legislative proposals as soon as a practicable and cost-efficient way of selecting polymers for registration on the basis of sound technical and valid scientific criteria can be established, and after publishing a report on the following:
(a) the risks posed by polymers in comparison with other substances;
(b) the need, if any, to register certain types of polymer, taking account of competitiveness and innovation on the one hand and the protection of human health
and the environment on the other.
3. The report, referred to in Article 117(4), on the experience acquired with the operation of this Regulation shall include a review of the requirements relating
to registration of substances manufactured or imported only in quantities starting at one tonne but less than 10 tonnes per year per manufacturer or importer. On the basis of that review, the Commission may present legislative proposals to modify the information requirements for
substances manufactured or imported in quantities of one tonne or more up to 10 tonnes per year per manufacturer or importer, taking into account the latest developments, for example in relation to alternative testing and (quantitative) structure-activity
relationships ((Q)SARs).
4. The Commission shall carry out a review of Annexes I, IV and V by 1 June 2008, with a view to proposing amendments, if appropriate, to them in accordance with the procedure referred to
in Article 131.
5. The Commission shall carry out a review of Annex XIII by 1 December 2008, to assess the adequacy of the criteria for identifying substances which are persistent, bioaccumulative and toxic or very persistent and very bioaccumulative, with a view to proposing an amendment to it, if appropriate, in accordance with the procedure referred to in Article 133(4).
6. By 1 June 2012 the Commission shall carry out a review to assess whether or not to amend the scope of this Regulation to
avoid overlaps with other relevant Community provisions. On the basis of that review, the Commission may, if appropriate,
present a legislative proposal.
7. By 1 June 2013 the Commission shall carry out a review to assess whether or not, taking into account latest developments
in scientific knowledge, to extend the scope of Article 60(3) to substances identified under Article 57(f) as having endocrine disrupting properties. On the basis of that review the Commission may, if appropriate, present legislative
proposals.
8. By 1 June 2019, the Commission shall carry out a review to assess whether or not to extend the scope of Article 33 to cover other dangerous substances, taking into account the practical experience in implementing that Article. On the basis of that review, the Commission may,
if appropriate, present legislative proposals to extend that obligation.
9. In accordance with the objective of promoting non-animal testing and the replacement, reduction or refinement of animal
testing required under this Regulation, the Commission shall review the testing requirements of Section 8.7 of Annex VIII by 1 June 2019. On the basis of this review, while ensuring a high level of protection of health and the environment, the
Commission may propose an amendment in accordance with the procedure referred to in Article 133(4).